Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 49 citing articles:

The role of m6A methylation in therapy resistance in cancer
Hengzhao Zhuang, Bo Yu, Dan Tao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 88
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 59
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy
Yu Du, Yu Zhou, Xinyu Yan, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 4, pp. 431-446
Closed Access | Times Cited: 24
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
METTL3: a multifunctional regulator in diseases
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 2
Small molecule inhibitors targeting m6A regulators
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 12
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer
Belinda J. Petri, Carolyn M. Klinge
Journal of Molecular Endocrinology (2022) Vol. 70, Iss. 2
Open Access | Times Cited: 32
METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma
Min Li, Mingyue Xia, Ziyu Zhang, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 3
Open Access | Times Cited: 26
m6A Modification Mediates Exosomal LINC00657 to Trigger Breast Cancer Progression Via Inducing Macrophage M2 Polarization
Jiafeng Chen, Yuxin Zhou, Minhua Wu, et al.
Clinical Breast Cancer (2023) Vol. 23, Iss. 5, pp. 546-560
Closed Access | Times Cited: 14
Correlation between ferroptosis and adriamycin resistance in breast cancer regulated by transferrin receptor and its molecular mechanism
Xiaojie Yu, Li‐Hao Cheng, Song Liu, et al.
The FASEB Journal (2024) Vol. 38, Iss. 5
Open Access | Times Cited: 5
Crosstalk between m6A regulators and mRNA during cancer progression
Xiaodong Niu, Yuan Yang, Yanming Ren, et al.
Oncogene (2022) Vol. 41, Iss. 39, pp. 4407-4419
Closed Access | Times Cited: 19
METTL3/YTHDC1-medicated m6A modification of circRNA3634 regulates the proliferation and differentiation of antler chondrocytes by miR-124486-5-MAPK1 axis
Mengmeng Song, Haibo Yao, Zitong Sun, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 11
METTL3 inhibitor STM2457 impairs tumor progression and enhances sensitivity to anlotinib in OSCC
Lianlian Liu, Tingting Zhao, Siyi Zheng, et al.
Oral Diseases (2024) Vol. 30, Iss. 7, pp. 4243-4254
Closed Access | Times Cited: 4
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
YTHDC1 negatively regulates UBE3A to influence RAD51 ubiquitination and inhibit apoptosis in colorectal cancer cells
Mingwei Gao, Yueguang Wu, Li Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms
Qiaoxi Xia, Rujia Zhong, Jingfang Zheng, et al.
Cell Reports (2025) Vol. 44, Iss. 4, pp. 115484-115484
Open Access
Poly-(ADP-ribose) serves as a scaffold for the methyltransferase METTL3/14 complex in the DNA damage response
Claudia Gonzalez-Leal, Jin Cai, Bram A F J de Groot, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 7
Open Access
Enhancing sensitivity of triple‐negative breast cancer to DNA‐damaging therapy through chemical inhibition of the m6A methyltransferase METTL3
Bianca Cesaro, Alessia Iaiza, F. Piscopo, et al.
Cancer Communications (2023) Vol. 44, Iss. 2, pp. 282-286
Open Access | Times Cited: 10
FTO suppresses DNA repair by inhibiting PARP1
Tianyi Zhu, Jing Zhi Anson Tan, Lingrui Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Immunomodulatory role of RNA modifications in sex hormone-dependent cancers
Yujia Jiang, X Liang, Huimin Sun, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
FTO‐mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR‐1343‐3p
Wei Lin, Caiqin Mo, Lingjun Kong, et al.
The Kaohsiung Journal of Medical Sciences (2023) Vol. 39, Iss. 9, pp. 873-882
Open Access | Times Cited: 8
Ginsenoside Rg3 combined with near‐infrared photothermal reversal of multidrug resistance in breast cancer MCF‐7/ADR cells
Ying Chang, Qiang Fu, Zhongqi Lu, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 8, pp. 5750-5761
Open Access | Times Cited: 3
METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor
Xin Chen, Miaomiao Wang, Haoran Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117366-117366
Open Access | Times Cited: 3
Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40
Yongmei Yin, Xin Yu, Feng Zhang, et al.
Neoplasia (2023) Vol. 39, pp. 100891-100891
Open Access | Times Cited: 7
Functions of methyltransferase-like 3 in breast cancer: pathogenesis, drug resistance, and therapeutic target
Dongqiong Xiao, Mingfu Zhang, Yi Qu, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top